KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Non-Current Deferred Tax Liability (2016 - 2026)

West Pharmaceutical Services has reported Non-Current Deferred Tax Liability over the past 18 years, most recently at $22.7 million for Q1 2026.

  • Quarterly Non-Current Deferred Tax Liability rose 6.57% to $22.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $22.7 million through Mar 2026, up 6.57% year-over-year, with the annual reading at $23.0 million for FY2025, 73.95% down from the prior year.
  • Non-Current Deferred Tax Liability was $22.7 million for Q1 2026 at West Pharmaceutical Services, down from $23.0 million in the prior quarter.
  • Over five years, Non-Current Deferred Tax Liability peaked at $88.3 million in Q4 2024 and troughed at $1.2 million in Q2 2022.
  • The 5-year median for Non-Current Deferred Tax Liability is $16.6 million (2022), against an average of $27.6 million.
  • Peak annual rise in Non-Current Deferred Tax Liability hit 1520.41% in 2022, while the deepest fall reached 90.16% in 2022.
  • Tracing WST's Non-Current Deferred Tax Liability over 5 years: stood at $79.4 million in 2022, then rose by 7.3% to $85.2 million in 2023, then grew by 3.64% to $88.3 million in 2024, then plummeted by 73.95% to $23.0 million in 2025, then dropped by 1.3% to $22.7 million in 2026.
  • According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods came in at $22.7 million, $23.0 million, and $22.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.